Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty
Primary Purpose
Anesthesia Complication
Status
Recruiting
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
Midazolam
Saline
Sponsored by

About this trial
This is an interventional treatment trial for Anesthesia Complication focused on measuring premedication, midazolam, opioids, remifentanil, Anesthesia, General
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) class I and II patients
- Patients who are scheduled for any elective surgery under general anesthesia
Exclusion Criteria:
- age <18 or >60 years
- current cervical spine disease or history of cervical spine surgery;
- morbid obesity (body mass index, ≥35 kg/m2);
- sleep apnea;
- craniofacial anomaly;
- allergic reaction to midazolam and remifentanil
- chronic use of opioid, benzodiazepine, antipsychotic medications
- pregnancy
- presence of muscle weakness or dyspnea
Sites / Locations
- Karaman Training and Research HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Group M
Group S
Arm Description
Patients of the Group M will be treated with midazolam premedication.
Group S patients are treated with 3 cc normal saline.
Outcomes
Primary Outcome Measures
Difficulty of mask ventilation (Warters grading scale 0-10)
The difficulty of mask ventilation will be assessed after 30 seconds from propofol induction (loss of consciousness) with Warter's scale.
The Warters scale assigns points based on escalating levels of intervention necessary to ventilate the lungs such as the use of an airway device, increased inspiratory pressure, and two-person ventilation, which are all intended to overcome upper airway resistance to ventilation. Additionally, the Warters scale accounts for situations in which a poor quality mask seal inhibits mask ventilation. Thus, in the event that the target tidal volume of 5 ml/kg is not achieved, and the provider is unable to generate a peak inspiratory pressure of >30 cmH20, additional points are assigned. The scale is scored between 0-10 and higher scores indicate worse mask application.
Secondary Outcome Measures
Anxiety level; Numerical Rating Scale(NRS) score (0 - 10)
The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 to 10 integers) that best reflects the intensity of their anxiety (0= very calm, 10= very anxious).
Sedation level (Modified Observer's assessment of alertness/sedation (MOAA/S) scale)
Before the intervention in the waiting area, and before the anesthetic induction in the operating room sedation levels were evaluated with MOAA/S scale. The Modified Observer's Assessment of Alertness/Sedation (MOAA/S) Scale was developed to measure the level of alertness in subjects who are sedated. The Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale is frequently used in sedation-related drug and device studies to assess a subject's level of sedation. The MOAA/S ranges from 0 to 5, with a score of 5 defined as awake or minimally sedated, and a score of 0 defined as general anesthesia.
Full Information
NCT ID
NCT05369819
First Posted
April 22, 2022
Last Updated
October 4, 2023
Sponsor
Karaman Training and Research Hospital
1. Study Identification
Unique Protocol Identification Number
NCT05369819
Brief Title
Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty
Official Title
Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty During General Anesthesia Induction: A Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 24, 2022 (Actual)
Primary Completion Date
November 1, 2023 (Anticipated)
Study Completion Date
November 15, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Karaman Training and Research Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Mask ventilation has great importance during anesthesia induction because it is the only way to oxygenate patients who have lost consciousness and spontaneous breathing. Opioid-derived drugs used in anesthesia induction may cause difficulty in mask ventilation due to their chest wall rigidity and respiratory depressant effects. Adequate muscle relaxation and depth of anesthesia may assist with mask ventilation. It is known that premedication reduces anxiety and has a relaxing effect on airway muscles. Midazolam is frequently used in premedication because it has a rapid onset of action and does not cause hemodynamic changes. In addition, midazolam may relax the airway by acting directly on the airway smooth muscle and thus facilitate mask ventilation during anesthesia induction. In this study, the investigators will evaluate the effect of midazolam premedication on the mask ventilation after induction with remifentanil.
Detailed Description
American Society of Anesthesiologists (ASA) class I and II patients who are admitted to undergoing elective surgery under general anesthesia will be enrolled. Patients in midazolam group (Group M) will be treated with midazolam premedication (3 cc mixture of 0.035 mg/kg midazolam and normal saline; maximum midazolam dose, 3 mg) intravenously in a waiting area 3 minutes before transportation to an operating room, while 3 cc normal saline will be administered to control group (Group S) patients. The difficulty of mask ventilation will be evaluated before the injection of neuromuscular blocking during general anesthetic induction. The anxiety and sedation levels of patients will be estimated before the intervention and before anesthetic induction in an operating room. Remifentanil will be used as an opioid in the induction of the patients. In anesthesia induction, propofol 1.5 mg/kg will be given after remifentanil is infused at a dose of 0.30 µg/kg/min for three minutes. Before the patients were given muscle relaxants, the patients were evaluated with the Warter scale
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anesthesia Complication
Keywords
premedication, midazolam, opioids, remifentanil, Anesthesia, General
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
The patients will be unaware of the group assignments and monitored in the reception area by a blinded anesthesiologist who will be in charge of the intervention and the evaluation of anxiety and sedation levels.
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group M
Arm Type
Experimental
Arm Description
Patients of the Group M will be treated with midazolam premedication.
Arm Title
Group S
Arm Type
Placebo Comparator
Arm Description
Group S patients are treated with 3 cc normal saline.
Intervention Type
Drug
Intervention Name(s)
Midazolam
Other Intervention Name(s)
Group M
Intervention Description
. Patients of the midazolam group will be treated with midazolam premedication (3 cc mixture of 0.035 mg/kg midazolam and normal saline; maximum midazolam dose, 3 mg) intravenously a waiting area 3 minutes before transportation to an operating room
Intervention Type
Drug
Intervention Name(s)
Saline
Other Intervention Name(s)
Group S
Intervention Description
Control group patients are treated with 3 cc normal saline in a waiting area 3 minutes before transportation to an operating room
Primary Outcome Measure Information:
Title
Difficulty of mask ventilation (Warters grading scale 0-10)
Description
The difficulty of mask ventilation will be assessed after 30 seconds from propofol induction (loss of consciousness) with Warter's scale.
The Warters scale assigns points based on escalating levels of intervention necessary to ventilate the lungs such as the use of an airway device, increased inspiratory pressure, and two-person ventilation, which are all intended to overcome upper airway resistance to ventilation. Additionally, the Warters scale accounts for situations in which a poor quality mask seal inhibits mask ventilation. Thus, in the event that the target tidal volume of 5 ml/kg is not achieved, and the provider is unable to generate a peak inspiratory pressure of >30 cmH20, additional points are assigned. The scale is scored between 0-10 and higher scores indicate worse mask application.
Time Frame
During surgery at 30 seconds after loss of consciousness
Secondary Outcome Measure Information:
Title
Anxiety level; Numerical Rating Scale(NRS) score (0 - 10)
Description
The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0 to 10 integers) that best reflects the intensity of their anxiety (0= very calm, 10= very anxious).
Time Frame
One minute before the intervention in waiting area, and one minute before the anesthetic induction in operating room
Title
Sedation level (Modified Observer's assessment of alertness/sedation (MOAA/S) scale)
Description
Before the intervention in the waiting area, and before the anesthetic induction in the operating room sedation levels were evaluated with MOAA/S scale. The Modified Observer's Assessment of Alertness/Sedation (MOAA/S) Scale was developed to measure the level of alertness in subjects who are sedated. The Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale is frequently used in sedation-related drug and device studies to assess a subject's level of sedation. The MOAA/S ranges from 0 to 5, with a score of 5 defined as awake or minimally sedated, and a score of 0 defined as general anesthesia.
Time Frame
One minute before the intervention in waiting area, and one minute before the anesthetic induction in operating room
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
American Society of Anesthesiologists (ASA) class I and II patients
Patients who are scheduled for any elective surgery under general anesthesia
Exclusion Criteria:
age <18 or >60 years
current cervical spine disease or history of cervical spine surgery;
morbid obesity (body mass index, ≥35 kg/m2);
sleep apnea;
craniofacial anomaly;
allergic reaction to midazolam and remifentanil
chronic use of opioid, benzodiazepine, antipsychotic medications
pregnancy
presence of muscle weakness or dyspnea
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rafet Yarımoglu, MD
Phone
+903382263320
Ext
3320
Email
rafety@hotmail.com.tr
First Name & Middle Initial & Last Name or Official Title & Degree
Betul Basaran, MD
Phone
+903382263320
Ext
3320
Email
betulbasaran1@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rafet Yarımoglu, MD
Organizational Affiliation
Karaman Training and Research Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karaman Training and Research Hospital
City
Karaman
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
RAFET YARIMOGLU, MD
Phone
+90 5356471902
Email
rafety@hotmail.com.tr
12. IPD Sharing Statement
Learn more about this trial
Effect of Midazolam Premedication on Opioid-induced Mask Ventilation Difficulty
We'll reach out to this number within 24 hrs